ARMANDO ANIDO
CIK 1219866 · Chairman & Chief Exec. Officer · last filed 2025-06-30
ARMANDO ANIDO is a Chairman & Chief Exec. Officer who has filed 70 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for SCYX, was dated Jun 30, 2025. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.27M
7
70
-$3.54M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 71,000 | $4.23 | $300.3K | $31.2K | 11 | 2025-06-30 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Chairman & Chief Exec. Officer | 0 | $1.30 | $0 | $130.0K | 17 | 2023-10-11 |
| AVIR | Director | — | $4.49 | — | $0 | 2 | 2017-05-22 |
| Vaxart, Inc. (BOTA) Delisted | Director | — | — | — | $0 | 1 | 2015-10-21 |
| PATH | Chief Executive Officer | 1,270,000 | $10.55 | $13.40M | $0 | 4 | 2013-01-22 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | CEO & President | 77,267 | — | — | -$3.71M | 26 | 2011-10-11 |
| RPRX | Director | 10,450 | $54.87 | $573.4K | $0 | 5 | 2010-05-19 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-30 | SCYX | Grant (A) | +23,000 | $0 | EDGAR |
| 2024-06-21 | SCYX | Grant (A) | +23,000 | $0 | EDGAR |
| 2023-10-11 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | −976,614 | $0 | EDGAR |
| 2023-09-14 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +46,917 | -$23.6K | EDGAR |
| 2023-06-23 | SCYX | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-06-20 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2023-02-09 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +32,859 | -$7.5K | EDGAR |
| 2023-02-02 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +30,711 | -$7.0K | EDGAR |
| 2023-01-25 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +214,547 | -$21.2K | EDGAR |
| 2022-07-20 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Mixed | +31,265 | -$13.1K | EDGAR |